Search - Université de Rennes Access content directly

Filter your results

28 Results
Structure: Internal structure identifier : 518500

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Roch Houot , Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean Marc Schiano de Collela et al.
Blood, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩
Journal articles hal-02076926v1

Pomalidomide plus low-dose dexamethasone in multiple myeloma with deletion 17p and/or translocation (4;14): IFM 2010-02 trial results.

Xavier Leleu , Lionel Karlin , Margaret Macro , Cyrille Hulin , Laurent Garderet et al.
Blood, 2015, 125 (9), pp.1411-7. ⟨10.1182/blood-2014-11-612069⟩
Journal articles hal-01141134v1

In Adults with Ph-Negative Acute Lymphoblastic Leukemia (ALL), Age-Adapted Chemotherapy Intensity and MRD-Driven Transplant Indication Significantly Reduces Treatment-Related Mortality (TRM) and Improves Overall Survival - Results from the Graall-2014 Trial

Nicolas Boissel , Francoise Huguet , Thibaut Leguay , Hunault-Berger Mathilde , Carlos Graux et al.
Blood, 2022, 140 (Supplement 1), pp.112-114. ⟨10.1182/blood-2022-157903⟩
Journal articles hal-04020877v1

Carfilzomib Weekly Plus Melphalan and Prednisone in Newly Diagnosed Elderly Multiple Myeloma (IFM 2012-03) / 57th Annual Meeting of the American-Society-of-Hematology - Orlando, FL

Xavier Leleu , Lionel Karlin , Brigitte Kolb , Mourad Tiab , Carla Araujo et al.
Blood, 2015, 126 (23), pp.3028
Journal articles hal-01290431v1

Is Arsenic Trioxide (ATO) Required in the Treatment of Standard Risk Newly Diagnosed APL? Analysis of a Randomized Trial (APL 2006) By the French Belgian Swiss APL Group

Lionel Adès , Xavier Thomas , Agnes Cuerci-Bres , Raffoux Emmanuel , Olivier Spertini et al.
Blood, 2015, 126 (23), pp.451
Journal articles hal-01300812v1
Image document

Safe and prolonged survival with Long-term exposure to Pomalidomide in Relapsed/Refractory Myeloma

G. Fouquet , B. Pégourié , M. Macro , M. O. Petillon , L. Karlin et al.
Annals of Oncology, 2016, 27 (5), pp.902-907. ⟨10.1093/annonc/mdw017⟩
Journal articles hal-01263111v1

Ofatumumab in refractory chronic lymphocytic leukemia: experience through the French early access program.

J Dupuis , P Brice , S François , Loic Ysebaert , S de Guibert et al.
Clinical Lymphoma, Myeloma & Leukemia, 2015, 15 (2), pp.e43-6. ⟨10.1016/j.clml.2014.07.013⟩
Journal articles hal-01162051v1

Double umbilical cord blood transplantation for hematological malignancies: a long- term analysis from the SFGM-TC registry.

Hélène Labussière Wallet , Mohamad Sobh , Stéphane Morisset , Marie Robin , Nathalie Fegueux et al.
Experimental Hematology, 2013, 41 (11), pp.924-933. ⟨10.1016/j.exphem.2013.05.297⟩
Journal articles hal-00849674v1

A 1-Year Prospective French Nationwide Study of Emergency Hospital Admissions in Children and Adults with Primary Immunodeficiency

Hélène Coignard-Biehler , Nizar Mahlaoui , Benoît Pilmis , Vincent Barlogis , Pauline Brosselin et al.
Journal of Clinical Immunology, 2019, 39 (7), pp.702-712. ⟨10.1007/s10875-019-00658-9⟩
Journal articles hal-02377907v1

Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study.

Raouf Ben Abdelali , Vahid Asnafi , Thibaut Leguay , Nicolas Boissel , Agnès Buzyn et al.
Blood, 2011, 118 (19), pp.5099-107. ⟨10.1182/blood-2011-02-334219⟩
Journal articles hal-00777203v1

2.27 Differential Gene Expression and Secretory Profiles of Nurse-like Cells Specifically Derived from Chronic Lymphocytic Leukemia Help Decipher New Pathways to Pathogenesis

Loic Ysebaert , Yovan Sanchez-Ruiz , Nais Prade , Jean-Philippe Guégan , Anne Quillet-Mary et al.
Clinical Lymphoma Myeloma and Leukemia, 2011, 11, pp.S175-S176. ⟨10.1016/j.clml.2011.09.060⟩
Journal articles istex hal-02348920v1

Molecular classification and prognosis in younger adults with acute myeloid leukemia and intermediate-risk cytogenetics treated or not by gemtuzumab ozogamycin: Final results of the GOELAMS/FILO acute myeloid leukemia 2006-intermediate-risk trial

Anne Bouvier , Jean-Francois Hamel , Jacques Delaunay , Eric Delabesse , Pierre-Yves Dumas et al.
European Journal of Haematology, 2021, 107 (1), pp.111-121. ⟨10.1111/ejh.13626⟩
Journal articles hal-03604930v1

A Phase 2 study of L-asparaginase encapsulated in erythrocytes in elderly patients with Philadelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL-SA2-2008 study

Mathilde Hunault-Berger , Thibaut Leguay , Françoise Huguet , Stéphane Leprêtre , Eric Deconinck et al.
American Journal of Hematology, 2015, 90 (9), pp.811--818. ⟨10.1002/ajh.24093⟩
Journal articles hal-01237093v1
Image document

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag , Serge Koscielny , Jacques Bosq , Thibaut Leguay , Olivier Casasnovas et al.
The Lancet, 2016, 387 (10036), pp.2402 - 2411. ⟨10.1016/S0140-6736(15)01317-3⟩
Journal articles inserm-01419476v1

Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.

Jean-Luc Harousseau , Herve Avet-Loiseau , Michel Attal , Catherine Charbonnel , Frederic Garban et al.
Journal of Clinical Oncology, 2009, 27 (34), pp.5720-6. ⟨10.1200/JCO.2008.21.1060⟩
Journal articles hal-00821143v1

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1

Salvage Therapy Post Pomalidomide-Based Regimen in Relapsed/Refractory Myeloma

Guillemette Fouquet , Lionel Karlin , Margaret Macro , Denis Caillot , Murielle Roussel et al.
Blood, 2015, 126 (23), pp.1831
Journal articles hal-01300804v1

Evolving characteristics and outcome of secondary acute promyelocytic leukemia (APL): A prospective analysis by the French-Belgian-Swiss APL group

Thorsten Braun , Sophie Cereja , Sylvie Chevret , Emmanuel Raffoux , Marie Beaumont et al.
Cancer, 2015, 121 (14), pp.2393-2399. ⟨10.1002/cncr.29389⟩
Journal articles hal-01237097v1

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL

Romain Guièze , Pauline Robbe , Ruth Clifford , Sophie De Guibert , Bruno Pereira et al.
Blood, 2015, 126 (18), pp.2110--2117. ⟨10.1182/blood-2015-05-647578⟩
Journal articles hal-01263113v1

Central Nervous System Involvement in Chronic Lymphocytic Leukemia: Diagnosis and Treatment in a Retrospective Cohort of Thirty Patients

Anne Wanquet , Rudy Birsen , Sylvain Choquet , Vincent Levy , Jehan Dupuis et al.
Blood, 2015, 126 (23), pp.2948
Journal articles hal-01290433v1

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Bruno Lioure , Marie C Béné , Arnaud Pigneux , Anne Huynh , Patrice Chevallier et al.
Blood, 2012, 119 (12), pp.2943-8. ⟨10.1182/blood-2011-05-352989⟩
Journal articles hal-00849702v1

Evaluation of Minimal Residual Disease (MRD) By Next Generation Sequencing (NGS) Is Highly Predictive of Progression Free Survival in the IFM/DFCI 2009 Trial

Herve Avet-Loiseau , Jill Corre , Valérie Lauwers-Cances , Marie-Lorraine Chretien , Nelly Robillard et al.
Blood, 2015, 126 (23), pp.191
Journal articles hal-01300806v1
Image document

Maintenance therapy with alternating azacitidine and lenalidomide in elderly fit patients with poor prognosis acute myeloid leukemia: a phase II multicentre FILO trial

Mathilde Hunault-Berger , N. Maillard , C. Himberlin , C. Recher , Aline Schmidt-Tanguy et al.
Blood Cancer Journal, 2017, 7 (6), pp.e568. ⟨10.1038/bcj.2017.50⟩
Journal articles inserm-01814864v1
Image document

Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience

Marie-Anne Couturier , Françoise Huguet , Patrice Chevallier , Felipe Suarez , Xavier Thomas et al.
American Journal of Hematology, 2015, 90 (11), pp.986--991. ⟨10.1002/ajh.24130⟩
Journal articles hal-01231425v1

Management of central nervous system involvement in chronic lymphocytic leukaemia: a retrospective cohort of 30 patients

Anne Wanquet , Rudy Birsen , Charlotte Bonnet , Marouane Boubaya , Sylvain Choquet et al.
British Journal of Haematology, 2017, 176 (1), pp.37 - 49. ⟨10.1111/bjh.14387⟩
Journal articles hal-01658794v1

Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02

Xavier Leleu , Michel Attal , Bertrand Arnulf , Philippe Moreau , Catherine Traulle et al.
Blood, 2013, 121 (11), pp.1968--1975. ⟨10.1182/blood-2012-09-452375⟩
Journal articles hal-01064417v1

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.

Mathilde Hunault-Berger , Thibaut Leguay , Xavier Thomas , Ollivier Legrand , Françoise Huguet et al.
Haematologica, 2011, 96 (2), pp.245-52. ⟨10.3324/haematol.2010.027862⟩
Journal articles hal-00821138v1

Addition of Lomustine (CCNU) to Induction and Post-Remission Chemotherapy for Fit Elderly AML Patients without Unfavorable Cytogenetics: Results of the Lamsa-2007 Goelams Trial

Arnaud Pigneux , Christian Récher , Marie C. Bene , Julien Asselineau , Ariane C. Mineur et al.
Blood, 2015, 126 (23)
Journal articles hal-01295674v1